UniProt ID | RBBP5_HUMAN | |
---|---|---|
UniProt AC | Q15291 | |
Protein Name | Retinoblastoma-binding protein 5 | |
Gene Name | RBBP5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 538 | |
Subcellular Localization | Nucleus . | |
Protein Description | In embryonic stem (ES) cells, plays a crucial role in the differentiation potential, particularly along the neural lineage, regulating gene induction and H3 'Lys-4' methylation at key developmental loci, including that mediated by retinoic acid (By similarity). As part of the MLL1/MLL complex, involved in mono-, di- and trimethylation at 'Lys-4' of histone H3. Histone H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation.. | |
Protein Sequence | MNLELLESFGQNYPEEADGTLDCISMALTCTFNRWGTLLAVGCNDGRIVIWDFLTRGIAKIISAHIHPVCSLCWSRDGHKLVSASTDNIVSQWDVLSGDCDQRFRFPSPILKVQYHPRDQNKVLVCPMKSAPVMLTLSDSKHVVLPVDDDSDLNVVASFDRRGEYIYTGNAKGKILVLKTDSQDLVASFRVTTGTSNTTAIKSIEFARKGSCFLINTADRIIRVYDGREILTCGRDGEPEPMQKLQDLVNRTPWKKCCFSGDGEYIVAGSARQHALYIWEKSIGNLVKILHGTRGELLLDVAWHPVRPIIASISSGVVSIWAQNQVENWSAFAPDFKELDENVEYEERESEFDIEDEDKSEPEQTGADAAEDEEVDVTSVDPIAAFCSSDEELEDSKALLYLPIAPEVEDPEENPYGPPPDAVQTSLMDEGASSEKKRQSSADGSQPPKKKPKTTNIELQGVPNDEVHPLLGVKGDGKSKKKQAGRPKGSKGKEKDSPFKPKLYKGDRGLPLEGSAKGKVQAELSQPLTAGGAISELL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MNLELLESFGQNYPE CCHHHHHHHCCCCCH | 34.35 | 22817900 | |
13 | Phosphorylation | LESFGQNYPEEADGT HHHHCCCCCHHCCCC | 12.25 | 22817900 | |
20 | Phosphorylation | YPEEADGTLDCISMA CCHHCCCCHHHHHHH | 21.70 | 22817900 | |
55 | Phosphorylation | IVIWDFLTRGIAKII EEEEECHHHHHHHHH | 27.18 | 20860994 | |
108 | Phosphorylation | DQRFRFPSPILKVQY CCCCCCCCCEEEEEE | 23.12 | 24719451 | |
112 | Ubiquitination | RFPSPILKVQYHPRD CCCCCEEEEEECCCC | 28.19 | - | |
122 | Ubiquitination | YHPRDQNKVLVCPMK ECCCCCCCEEEEECC | 31.17 | - | |
129 | Sumoylation | KVLVCPMKSAPVMLT CEEEEECCCCCEEEE | 28.71 | 28112733 | |
129 | Ubiquitination | KVLVCPMKSAPVMLT CEEEEECCCCCEEEE | 28.71 | - | |
130 | Phosphorylation | VLVCPMKSAPVMLTL EEEEECCCCCEEEEC | 31.39 | 19664994 | |
136 | Phosphorylation | KSAPVMLTLSDSKHV CCCCEEEECCCCCEE | 13.20 | 21406692 | |
138 | Phosphorylation | APVMLTLSDSKHVVL CCEEEECCCCCEEEE | 34.30 | 20068231 | |
140 | Phosphorylation | VMLTLSDSKHVVLPV EEEECCCCCEEEEEC | 22.68 | 21406692 | |
162 | Methylation | VVASFDRRGEYIYTG EEEEEECCCCEEEEC | 44.11 | 115490407 | |
165 | Phosphorylation | SFDRRGEYIYTGNAK EEECCCCEEEECCCC | 11.31 | 20068231 | |
167 | Phosphorylation | DRRGEYIYTGNAKGK ECCCCEEEECCCCCE | 14.00 | 20068231 | |
168 | Phosphorylation | RRGEYIYTGNAKGKI CCCCEEEECCCCCEE | 17.88 | 20068231 | |
172 | Ubiquitination | YIYTGNAKGKILVLK EEEECCCCCEEEEEE | 65.81 | - | |
180 | Phosphorylation | GKILVLKTDSQDLVA CEEEEEECCCCCEEE | 36.40 | 20068231 | |
182 | Phosphorylation | ILVLKTDSQDLVASF EEEEECCCCCEEEEE | 30.72 | 17525332 | |
188 | Phosphorylation | DSQDLVASFRVTTGT CCCCEEEEEEEEECC | 13.20 | 20068231 | |
193 | Phosphorylation | VASFRVTTGTSNTTA EEEEEEEECCCCCCE | 35.29 | 17525332 | |
195 | Phosphorylation | SFRVTTGTSNTTAIK EEEEEECCCCCCEEE | 19.40 | 20860994 | |
196 | Phosphorylation | FRVTTGTSNTTAIKS EEEEECCCCCCEEEE | 33.26 | 29759185 | |
198 | Phosphorylation | VTTGTSNTTAIKSIE EEECCCCCCEEEEEE | 19.85 | 20860994 | |
199 | Phosphorylation | TTGTSNTTAIKSIEF EECCCCCCEEEEEEE | 30.54 | 20860994 | |
202 | Malonylation | TSNTTAIKSIEFARK CCCCCEEEEEEEHHC | 42.80 | 26320211 | |
202 | Ubiquitination | TSNTTAIKSIEFARK CCCCCEEEEEEEHHC | 42.80 | - | |
202 | Acetylation | TSNTTAIKSIEFARK CCCCCEEEEEEEHHC | 42.80 | 26051181 | |
209 | Acetylation | KSIEFARKGSCFLIN EEEEEHHCCCEEEEE | 52.31 | 26051181 | |
211 | Phosphorylation | IEFARKGSCFLINTA EEEHHCCCEEEEECC | 12.53 | 23927012 | |
244 (in isoform 2) | Ubiquitination | - | 41.69 | 21890473 | |
244 | Ubiquitination | GEPEPMQKLQDLVNR CCCCHHHHHHHHHHC | 41.69 | 21890473 | |
252 | Phosphorylation | LQDLVNRTPWKKCCF HHHHHHCCCCCCCCC | 28.44 | 25159151 | |
256 | Ubiquitination | VNRTPWKKCCFSGDG HHCCCCCCCCCCCCC | 32.16 | - | |
279 (in isoform 1) | Ubiquitination | - | 8.07 | 21890473 | |
281 | Acetylation | HALYIWEKSIGNLVK CCEEEEHHHHHHHHH | 32.17 | 19608861 | |
345 | Phosphorylation | ELDENVEYEERESEF HHHHCCCHHHHHCCC | 20.86 | 23917254 | |
350 | Phosphorylation | VEYEERESEFDIEDE CCHHHHHCCCCCCCC | 50.19 | 28355574 | |
378 | Phosphorylation | EDEEVDVTSVDPIAA CCCCCCCCEECHHHH | 20.69 | 27251275 | |
379 | Phosphorylation | DEEVDVTSVDPIAAF CCCCCCCEECHHHHH | 25.11 | 27251275 | |
388 | Phosphorylation | DPIAAFCSSDEELED CHHHHHCCCCHHHCC | 34.08 | 17081983 | |
389 | Phosphorylation | PIAAFCSSDEELEDS HHHHHCCCCHHHCCC | 50.66 | 17081983 | |
396 | Phosphorylation | SDEELEDSKALLYLP CCHHHCCCCEEEEEE | 15.51 | 26074081 | |
397 | Sumoylation | DEELEDSKALLYLPI CHHHCCCCEEEEEEC | 56.21 | - | |
401 | Phosphorylation | EDSKALLYLPIAPEV CCCCEEEEEECCCCC | 15.98 | 26074081 | |
425 | Phosphorylation | PPPDAVQTSLMDEGA CCCCHHHHHHCCCCC | 19.75 | 28348404 | |
426 | Phosphorylation | PPDAVQTSLMDEGAS CCCHHHHHHCCCCCC | 12.47 | 22210691 | |
433 | Phosphorylation | SLMDEGASSEKKRQS HHCCCCCCCHHHHHC | 50.30 | 28348404 | |
434 | Phosphorylation | LMDEGASSEKKRQSS HCCCCCCCHHHHHCC | 53.56 | 22210691 | |
440 | Phosphorylation | SSEKKRQSSADGSQP CCHHHHHCCCCCCCC | 31.37 | 28985074 | |
441 | Phosphorylation | SEKKRQSSADGSQPP CHHHHHCCCCCCCCC | 23.26 | 25262027 | |
445 | Phosphorylation | RQSSADGSQPPKKKP HHCCCCCCCCCCCCC | 39.81 | 20446291 | |
455 | Phosphorylation | PKKKPKTTNIELQGV CCCCCCCCCEEEECC | 40.08 | 28555341 | |
474 | Acetylation | VHPLLGVKGDGKSKK CCCCCCCCCCCCCCC | 49.87 | 26051181 | |
490 (in isoform 2) | Phosphorylation | - | 44.34 | 20068231 | |
497 | Phosphorylation | SKGKEKDSPFKPKLY CCCCCCCCCCCCCCC | 43.22 | 23401153 | |
500 | Acetylation | KEKDSPFKPKLYKGD CCCCCCCCCCCCCCC | 44.63 | 23749302 | |
515 | Phosphorylation | RGLPLEGSAKGKVQA CCCCCCCCCCCCEEE | 19.89 | 25159151 | |
517 | Acetylation | LPLEGSAKGKVQAEL CCCCCCCCCCEEEEE | 62.05 | 25953088 | |
525 | Phosphorylation | GKVQAELSQPLTAGG CCEEEEECCCCCCCC | 22.66 | 25159151 | |
529 | Phosphorylation | AELSQPLTAGGAISE EEECCCCCCCCHHHH | 29.91 | 23663014 | |
535 | Phosphorylation | LTAGGAISELL---- CCCCCHHHHHC---- | 22.97 | 20068231 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RBBP5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBBP5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-281, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-182 AND THR-193, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350; SER-388; SER-389AND SER-497, AND MASS SPECTROMETRY. |